KYNB
KYNB
NASDAQ · Biotechnology

Kyntra Bio Inc

$6.90
-0.04 (-0.58%)
As of Sep 28, 10:33 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +362.5% upside
Low Target $24.67
Average Target $31.91
High Target $44.05
Current Price $6.90
Current
$6.90
Target
$31.91
$24.67 $31.91 avg $44.05
Scenario Analysis
Bear Case
$24.67
257.5%
Low target
Base Case
$31.91
+362.5%
Avg target
Bull Case
$44.05
+538.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$12.58
-45.2% from high
52-Week Low
$6.32
+9.2% from low
Target vs 52W High
$31.91
+153.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%